Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.360NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.360NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.578ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.578NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.578NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.544ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.544NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.544NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.448ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.448NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.448NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.425ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.425NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.425NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.1.354ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.354NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.1.354NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.503ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.503NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.503NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.36.31ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.31NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.36.31NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.623ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.623NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-18743.8China
B.1.623NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.214.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.214.3NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.214.3NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.588ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.588NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
B.1.588NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.210ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.210NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.210NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
A.28ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
A.28NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
A.28NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.567ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.567NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.567NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
C.23ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
C.23NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
C.23NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
C.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
C.2.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
C.2.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.541ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.541NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.541NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used